Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
05 06 2019
05 06 2019
Historique:
entrez:
8
6
2019
pubmed:
8
6
2019
medline:
19
2
2020
Statut:
epublish
Résumé
Anorexia nervosa is recognized as an important cause of morbidity in young people. However, the risk of cancer in people with anorexia nervosa remains uncertain. To evaluate the association of anorexia nervosa with the risk of developing or dying of cancer. MEDLINE, Scopus, Embase, and Web of Science from database inception to January 9, 2019. Published observational studies in humans examining the risk of cancer in people with anorexia nervosa compared with the general population or those without anorexia nervosa. Studies needed to report incidence or mortality rate ratios (RRs). Screening, data extraction, and methodological quality assessment were performed by at least 2 researchers independently. A random-effects model was used to synthesize individual studies. Heterogeneity (I2) was assessed and 95% prediction intervals (PIs) were calculated. All cancer incidence and cancer mortality associated with anorexia nervosa. Secondary outcomes were site-specific cancer incidence and mortality. Seven cohort studies published in 10 articles (42 602 participants with anorexia nervosa) were included. Anorexia nervosa was not associated with risk of developing any cancer (4 studies in women; RR, 0.97; 95% CI, 0.89-1.06; P = .53; I2, 0%; 95% PI, 0.80-1.18; moderate confidence). Anorexia nervosa was associated with decreased breast cancer incidence (5 studies in women; RR, 0.60; 95% CI, 0.50-0.80; P < .001; I2, 0%; 95% PI, 0.44-0.83; high confidence). Conversely, anorexia nervosa was associated with increased risk of developing lung cancer (3 studies in women; RR, 1.50; 95% CI, 1.06-2.12; P = .001; I2, 0%; 95% PI, 0.19-16.46; low confidence) and esophageal cancer (2 studies in women; RR, 6.10; 95% CI, 2.30-16.18; P < .001; I2, 0%; low confidence). Among people with anorexia nervosa, risk of developing cancer did not differ compared with the general population, but a significantly reduced risk of breast cancer was observed. Understanding the mechanisms underlying these associations could have important preventive potential.
Identifiants
pubmed: 31173122
pii: 2735463
doi: 10.1001/jamanetworkopen.2019.5313
pmc: PMC6563572
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e195313Références
Lancet Oncol. 2017 Dec;18(12):1579-1589
pubmed: 29111259
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
Lancet Psychiatry. 2015 Dec;2(12):1099-111
pubmed: 26514083
Mayo Clin Proc. 2003 Mar;78(3):278-84
pubmed: 12630579
Br J Psychiatry. 2009 Jan;194(1):10-7
pubmed: 19118319
BMJ. 2011 Feb 10;342:d549
pubmed: 21310794
Cancer Causes Control. 2001 Feb;12(2):173-7
pubmed: 11246846
Addiction. 2016 Nov;111(11):1914-1922
pubmed: 27206671
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Am J Psychiatry. 1995 Jul;152(7):1073-4
pubmed: 7793446
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Eur J Cancer Prev. 2009 Jun;18(3):207-11
pubmed: 19491607
Breast Cancer. 2018 May;25(3):259-267
pubmed: 29651637
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Lancet Diabetes Endocrinol. 2014 Jul;2(7):581-92
pubmed: 24731664
Syst Rev. 2017 Jul 11;6(1):137
pubmed: 28693568
Lancet Oncol. 2011 Jun;12(6):604-8
pubmed: 21498115
Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):206-211
pubmed: 27756775
JAMA. 2004 Mar 10;291(10):1226-30
pubmed: 15010444
JAMA Oncol. 2018 Nov 1;4(11):e181771
pubmed: 29931120
J Clin Endocrinol Metab. 2011 Feb;96(2):333-43
pubmed: 21159848
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
BMJ Clin Evid. 2011 Apr 11;2011:
pubmed: 21481284
JAMA Oncol. 2019 Feb 1;5(2):155-163
pubmed: 30520976
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
JAMA Oncol. 2015 Aug;1(5):611-21
pubmed: 26182172
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Recent Results Cancer Res. 2016;207:241-66
pubmed: 27557543
Int J Cancer. 2014 Apr 1;134(7):1751-7
pubmed: 24114497
BMJ. 2017 Oct 26;359:j4511
pubmed: 29074629
Int J Cancer. 2003 Sep 20;106(5):766-70
pubmed: 12866038
Breast Cancer Res Treat. 2018 Apr;168(2):495-500
pubmed: 29235044
Arch Gen Psychiatry. 2011 Jul;68(7):724-31
pubmed: 21727255
Ann Intern Med. 2019 Jan 1;170(1):22-30
pubmed: 30534999
Mayo Clin Proc. 2014 Apr;89(4):548-57
pubmed: 24684876
PLoS One. 2015 May 22;10(5):e0128018
pubmed: 26000630
Cancer Metab. 2013 Mar 07;1(1):10
pubmed: 24280167
Cancer Epidemiol. 2015 Jun;39(3):313-20
pubmed: 25769223
Nat Rev Cancer. 2018 Nov;18(11):707-719
pubmed: 30327499
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120